| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
15,268 |
13,715 |
$4.84M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12,882 |
11,889 |
$3.86M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,370 |
1,310 |
$1.84M |
| G0378 |
Hospital observation service, per hour |
2,339 |
1,861 |
$1.30M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,291 |
3,113 |
$597K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,079 |
2,833 |
$559K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
8,230 |
1,988 |
$439K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
335 |
306 |
$428K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
234 |
214 |
$282K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,126 |
1,694 |
$263K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
5,927 |
1,396 |
$238K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,007 |
1,964 |
$223K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
6,685 |
1,553 |
$217K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,237 |
2,104 |
$192K |
| 76642 |
|
1,788 |
1,615 |
$168K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
11,698 |
10,200 |
$163K |
| 80053 |
Comprehensive metabolic panel |
19,395 |
15,890 |
$153K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,603 |
3,346 |
$140K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,885 |
1,789 |
$130K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,680 |
5,022 |
$121K |
| 77066 |
Tomosynthesis, mammo |
827 |
787 |
$120K |
| 71046 |
Radiologic examination, chest; 2 views |
5,171 |
4,883 |
$98K |
| OP370 |
|
4,785 |
4,323 |
$94K |
| OP272 |
|
6,439 |
5,788 |
$89K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,557 |
1,490 |
$89K |
| 77065 |
Tomosynthesis, mammo |
745 |
713 |
$84K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
506 |
458 |
$83K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,444 |
3,917 |
$80K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
21,193 |
17,059 |
$77K |
| 97010 |
|
7,183 |
1,625 |
$69K |
| 76830 |
Ultrasound, transvaginal |
862 |
827 |
$68K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,579 |
1,510 |
$68K |
| 92582 |
|
284 |
270 |
$67K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
634 |
596 |
$60K |
| 36415 |
Collection of venous blood by venipuncture |
21,513 |
16,726 |
$59K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,457 |
1,414 |
$57K |
| 71045 |
Radiologic examination, chest; single view |
5,828 |
5,292 |
$57K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
3,094 |
2,853 |
$55K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,175 |
1,985 |
$50K |
| 92567 |
|
803 |
755 |
$49K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,985 |
3,435 |
$49K |
| 82962 |
|
5,698 |
3,551 |
$33K |
| 97162 |
|
764 |
675 |
$32K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,146 |
1,051 |
$32K |
| OP710 |
|
1,312 |
1,153 |
$31K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
917 |
881 |
$29K |
| 73564 |
|
1,230 |
1,098 |
$28K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
29 |
27 |
$27K |
| 72110 |
|
850 |
818 |
$27K |
| 92588 |
|
105 |
103 |
$26K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,253 |
2,529 |
$26K |
| 84484 |
|
8,316 |
6,748 |
$26K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,620 |
3,927 |
$25K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
433 |
403 |
$23K |
| 93971 |
|
396 |
357 |
$21K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,891 |
1,732 |
$18K |
| 85027 |
|
2,790 |
2,398 |
$18K |
| 92556 |
|
137 |
128 |
$17K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
159 |
158 |
$17K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,966 |
2,576 |
$17K |
| 92557 |
|
81 |
76 |
$16K |
| 80061 |
Lipid panel |
1,550 |
1,444 |
$15K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,596 |
3,711 |
$15K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
182 |
173 |
$14K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,586 |
1,199 |
$14K |
| 92550 |
|
131 |
128 |
$14K |
| 83735 |
|
2,986 |
2,267 |
$13K |
| OP250 |
|
36,722 |
18,569 |
$13K |
| OP258 |
|
19,311 |
12,983 |
$13K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
392 |
369 |
$12K |
| 73030 |
|
721 |
674 |
$12K |
| 93017 |
|
83 |
83 |
$12K |
| 85610 |
|
2,898 |
2,577 |
$11K |
| 83690 |
|
5,372 |
4,712 |
$11K |
| 73630 |
|
934 |
871 |
$11K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,899 |
1,704 |
$11K |
| 81025 |
|
6,484 |
5,914 |
$10K |
| 97161 |
|
218 |
217 |
$10K |
| 81001 |
|
5,656 |
5,144 |
$10K |
| 92579 |
|
53 |
52 |
$9K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
380 |
339 |
$9K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,724 |
2,511 |
$9K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
425 |
384 |
$9K |
| 85730 |
|
2,418 |
2,168 |
$9K |
| 88313 |
|
664 |
631 |
$9K |
| 83880 |
|
1,783 |
1,571 |
$9K |
| J2704 |
Injection, propofol, 10 mg |
4,318 |
3,673 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,243 |
1,139 |
$8K |
| 73610 |
|
745 |
686 |
$7K |
| 88312 |
|
878 |
833 |
$7K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
88 |
65 |
$7K |
| 88342 |
|
445 |
411 |
$7K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,245 |
4,564 |
$6K |
| 81003 |
|
4,193 |
3,904 |
$6K |
| 73130 |
|
457 |
426 |
$6K |
| 96376 |
|
804 |
693 |
$6K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,153 |
1,492 |
$6K |
| OP270 |
|
3,040 |
2,829 |
$6K |
| 90791 |
Psychiatric diagnostic evaluation |
334 |
280 |
$5K |
| 93970 |
|
28 |
26 |
$5K |
| 0012A |
|
204 |
204 |
$5K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
41 |
39 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,006 |
855 |
$5K |
| 95800 |
|
12 |
12 |
$5K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,349 |
1,196 |
$5K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
961 |
789 |
$5K |
| 82607 |
|
461 |
427 |
$5K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
313 |
288 |
$5K |
| 0011A |
|
177 |
177 |
$4K |
| 90715 |
|
344 |
323 |
$4K |
| 84439 |
|
577 |
535 |
$4K |
| 77080 |
|
41 |
38 |
$3K |
| 74018 |
|
187 |
179 |
$3K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
32 |
32 |
$3K |
| 0064A |
|
108 |
102 |
$3K |
| 0002A |
|
86 |
86 |
$3K |
| 72052 |
|
57 |
57 |
$3K |
| 82948 |
|
176 |
94 |
$3K |
| 0001A |
|
84 |
82 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
625 |
439 |
$3K |
| 82077 |
|
1,350 |
1,137 |
$3K |
| 87070 |
|
1,285 |
1,220 |
$2K |
| 86850 |
|
804 |
717 |
$2K |
| 0004A |
|
63 |
62 |
$2K |
| 85379 |
|
1,328 |
1,224 |
$2K |
| J3490 |
Unclassified drugs |
886 |
751 |
$2K |
| 0071A |
|
38 |
38 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
405 |
349 |
$2K |
| 86900 |
|
810 |
725 |
$2K |
| 0072A |
|
34 |
34 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,340 |
1,273 |
$1K |
| 86901 |
|
810 |
724 |
$1K |
| 85007 |
|
95 |
90 |
$1K |
| 73110 |
|
107 |
95 |
$1K |
| 87040 |
|
256 |
195 |
$1K |
| 76536 |
|
14 |
13 |
$1K |
| 87400 |
|
536 |
532 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
488 |
422 |
$918.63 |
| 92593 |
|
15 |
13 |
$840.07 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
123 |
100 |
$834.96 |
| 83605 |
|
177 |
145 |
$801.40 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
620 |
430 |
$780.56 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
51 |
49 |
$684.43 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
13 |
13 |
$631.62 |
| V5020 |
Conformity evaluation |
26 |
25 |
$615.20 |
| 82550 |
|
582 |
513 |
$544.01 |
| 73502 |
|
76 |
71 |
$533.84 |
| 84100 |
|
659 |
460 |
$516.97 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,240 |
1,084 |
$466.65 |
| J2060 |
Injection, lorazepam, 2 mg |
418 |
327 |
$448.98 |
| 80306 |
|
225 |
197 |
$437.56 |
| A4618 |
Breathing circuits |
631 |
559 |
$437.03 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
227 |
200 |
$424.72 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
710 |
369 |
$423.53 |
| 82746 |
|
40 |
38 |
$387.79 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
375 |
270 |
$384.78 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
183 |
148 |
$365.51 |
| 85651 |
|
351 |
304 |
$356.60 |
| 80143 |
|
225 |
184 |
$332.99 |
| 80179 |
|
169 |
138 |
$318.08 |
| 84702 |
|
90 |
84 |
$287.51 |
| 0124A |
|
16 |
13 |
$249.17 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
32 |
29 |
$241.39 |
| C9113 |
Injection, pantoprazole sodium, per vial |
501 |
366 |
$200.84 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
743 |
669 |
$195.84 |
| 73080 |
|
12 |
12 |
$176.79 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
348 |
280 |
$172.60 |
| 87186 |
|
114 |
97 |
$158.30 |
| J1815 |
Injection, insulin, per 5 units |
34 |
12 |
$146.48 |
| 71101 |
|
25 |
24 |
$142.19 |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
49 |
36 |
$131.87 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
260 |
122 |
$109.98 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
94 |
88 |
$104.64 |
| 88341 |
|
24 |
24 |
$101.13 |
| J1644 |
Injection, heparin sodium, per 1000 units |
146 |
47 |
$75.81 |
| 84550 |
|
33 |
29 |
$62.15 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
40 |
17 |
$58.64 |
| 87088 |
|
69 |
59 |
$52.17 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
16 |
15 |
$38.00 |
| 91301 |
|
354 |
343 |
$38.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
114 |
86 |
$37.96 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
69 |
53 |
$35.73 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
23 |
16 |
$28.06 |
| 97116 |
|
32 |
12 |
$24.97 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
23 |
15 |
$24.92 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
185 |
144 |
$17.06 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
33 |
24 |
$16.82 |
| 82040 |
|
19 |
12 |
$12.67 |
| 96367 |
|
16 |
12 |
$9.27 |
| 80076 |
|
19 |
15 |
$8.96 |
| OP637 |
|
3,749 |
714 |
$7.08 |
| 91300 |
|
218 |
191 |
$5.00 |
| 91307 |
|
43 |
38 |
$3.00 |
| 91306 |
|
98 |
91 |
$2.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
12 |
12 |
$1.73 |
| 74022 |
|
12 |
12 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
13 |
13 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
13 |
13 |
$0.00 |
| 91312 |
|
16 |
13 |
$0.00 |